Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lounes, K. C.
Right arrow Articles by Soria, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lounes, K. C.
Right arrow Articles by Soria, J.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 November 2000, Vol. 96, No. 10, pp. 3473-3479

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY

Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma -Asp330 right-arrow Val) characterized by a defective fibrin polymerization site "a"

Karim Chabane Lounes, Claudine Soria, Shah Sultan Mirshahi, Pierre Desvignes, Massoud Mirshahi, Olivier Bertrand, Pierre Bonnet, Jaap Koopman, and Jeannette Soria

From the Laboratoire Sainte Marie, Laboratoire de Biochimie A, and INSERM E 99-12, Hôtel-Dieu, Paris; Laboratoire Diféma, Faculté de Médecine et de Pharmacie, Rouen; INSERM U. 153, Hôpital Saint Louis, Paris; Centre Hospitalier Régional, Martigues; INSERM U.76, Agence du sang, Paris; Centre Hopitalier Régional, Alès, France; and TNO-PG, Gaubius Laboratory, and Pharming, Leiden, The Netherlands.

Congenital homozygous dysfibrinogenemia was diagnosed in a man with a history of 2 thrombotic strokes before age 30. His hemostatic profile was characterized by a dramatically prolonged plasma thrombin clotting time, and no clotting was observed with reptilase. Complete clotting of the abnormal fibrinogen occurred after a prolonged incubation of plasma with thrombin. The release of fibrinopeptides A and B by thrombin and of fibrinopeptide A by reptilase were both normal. Thrombin-induced fibrin polymerization was impaired, and no polymerization occurred with reptilase. The polymerization defect was characterized by a defective site "a," resulting in an absence of interaction between sites A and a, indicated by the lack of fragment D1 (or fibrinogen) binding to normal fibrin monomers depleted in fibrinopeptide A only (Des-AA fm). By SDS-PAGE, the defect was detected on the gamma -chain and in its fragment D1. The molecular defect determined by analysis of genomic DNA showed a single base change (Aright-arrowT) in exon VIII of the gamma -chain. The resulting change in the amino acid structure is gamma  330 aspartic acid (GAT) right-arrow valine (GTT). It is concluded that the residue gamma -Asp330 is essential for the normal functioning of the polymerization site a on the fibrinogen gamma -chain.

© 2000 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020